RU94037731A - Method for treating multiple sclerosis - Google Patents

Method for treating multiple sclerosis

Info

Publication number
RU94037731A
RU94037731A RU94037731/14A RU94037731A RU94037731A RU 94037731 A RU94037731 A RU 94037731A RU 94037731/14 A RU94037731/14 A RU 94037731/14A RU 94037731 A RU94037731 A RU 94037731A RU 94037731 A RU94037731 A RU 94037731A
Authority
RU
Russia
Prior art keywords
multiple sclerosis
treating multiple
drug
symptomatic
immune system
Prior art date
Application number
RU94037731/14A
Other languages
Russian (ru)
Inventor
А.П. Ельчанинов
Ю.В. Медведев
Original Assignee
Акционерное общество закрытого типа Научно-производственная компания "Олифен"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Акционерное общество закрытого типа Научно-производственная компания "Олифен" filed Critical Акционерное общество закрытого типа Научно-производственная компания "Олифен"
Priority to RU94037731/14A priority Critical patent/RU94037731A/en
Publication of RU94037731A publication Critical patent/RU94037731A/en

Links

Abstract

FIELD: medicine. SUBSTANCE: method involves applying a drug stimulating immune system on the background of symptomatic and supporting therapy. Olyphen is selected as the drug mentioned. It is given at therapeutic intravenous and/or peroral doses. EFFECT: enhanced effectiveness of treatment.

Claims (1)

Способ лечения рассеянного склероза заключается в том, что в качестве вещества, воздействующего на иммунную систему на фоне симптоматического и поддерживающего лечения, применяют препарат "Олифен" в терапевтических дозах внутривенно и/или перорально.A method of treating multiple sclerosis is that as a substance affecting the immune system against the background of symptomatic and supportive treatment, the drug "Olifen" is used in therapeutic doses intravenously and / or orally.
RU94037731/14A 1994-09-30 1994-09-30 Method for treating multiple sclerosis RU94037731A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU94037731/14A RU94037731A (en) 1994-09-30 1994-09-30 Method for treating multiple sclerosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU94037731/14A RU94037731A (en) 1994-09-30 1994-09-30 Method for treating multiple sclerosis

Publications (1)

Publication Number Publication Date
RU94037731A true RU94037731A (en) 1996-07-20

Family

ID=48449467

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94037731/14A RU94037731A (en) 1994-09-30 1994-09-30 Method for treating multiple sclerosis

Country Status (1)

Country Link
RU (1) RU94037731A (en)

Similar Documents

Publication Publication Date Title
HUT60630A (en) Process or producing peroral pharmaceutical compositions suitable for treating internal diseases of inflammatory nature
GEP20002146B (en) Therapeutic Peptide Derivatives
ATE209908T1 (en) RADICAL CAPTURER (ßSPIN TRAPSß) FOR THE TREATMENT OF DISEASES ASSOCIATED WITH OXIDATION OF LIPIDS AND PROTEINS
NO306377B1 (en) Dosage form for delivery of a drug
KR950700749A (en) Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and a S-phase or M phase specific antineoplastic agent)
BG101118A (en) Therapeutical compounds
ES2173111T3 (en) USE OF FENSERINE FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF COGNOSCITIVE DISORDERS.
DE69426334D1 (en) Parenteral busulfan for the treatment of malignant diseases
DE69424777T2 (en) 3,4-DIARYLCHROMANE FOR TREATING DERMATITIS
RU95101385A (en) Products containing g-csf and tnf-binding protein
RU94041028A (en) Application of melatonin derivatives for treating desynchronization disorders, pharmaceutical composition
RU94037731A (en) Method for treating multiple sclerosis
NO984196D0 (en) Procedure for the treatment of substance abuse
SE9101341D0 (en) NEW MEDICINAL USE
NO961180L (en) Transdermal device containing (E) -2- (p-fluorophenethyl) -3-fluoroallylamine for the treatment of Alzheimer's disease
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
RU94036344A (en) Method for treating aids cases
RU94018543A (en) Method for treating the cases of trigeminal nerve neuralgia
RU94045317A (en) Method for treatment of encephalomyelitis
RU94002713A (en) Method for treating children possessing elongated qt interval syndrome
RU94020918A (en) Method for treating the cases of opsomenorrhea
RU95106400A (en) Method of prevention and treatment of diphtheria neuropathy in experiment
RU95116093A (en) METHOD FOR TREATING PATIENTS WITH ACUTE EXO- AND ENDOTOXICOSIS
RU93008439A (en) A method for the treatment of chronic purulent mean otitis
GEP20012366B (en) Thienyl-, Furil-, Pyrrolyl- and Biphenyl-Sulfonamides, Their Derivatives, Their Use in Medicinal Purposes, Pharmaceutical Composition Containing the Same and Method for Treatment